IsraCann Bioscience
Israel’s First Pure-Play Cannabis Firm
Business Branding
About IsraCann Bioscience
Isracann, Israel’s first pure-play cannabis firm, is focused on becoming a premier, low-cost cannabis producer. Isracann is fully funded to execute on over 230,000 sq ft of hybrid greenhouse.
The company is targeting undersupplied domestic demand combined with an immense international market opportunity through Israel’s new medical cannabis export framework for 2020.
Participation in events
- Cannabis Investors & Operators Conferenc...
- 200 N Columbus Dr, Chicago, IL 60601, US...
